{"chunk_type":"transcript_chunk","text":"---\n## 7. Pediatric Airway Sounds ğŸ‘¶\n- **Laryngomalacia (í›„ë‘ì—°í™”ì¦):**\n    - **Inspiratory Stridor (í¡ê¸°ì‹œ í˜‘ì°©ìŒ).**\n    - **Worse when Supine (ëˆ„ìš°ë©´ ì•…í™”)**, Better when Prone (ì—ë“œë¦¬ë©´ í˜¸ì „).\n    - **Prognosis:** Reassurance (ìì—° í˜¸ì „ë¨).\n- **Vascular Ring (í˜ˆê´€ ê³ ë¦¬):**\n    - **Worse with Feeding.**\n    - **Better with Neck Extension** (ëª©ì„ ë’¤ë¡œ ì –íˆë©´ ê¸°ë„ê°€ í´ì ¸ì„œ ì†Œë¦¬ê°€ ì¤„ì–´ë“¦).\n    - Cf. Retropharyngeal abscess: neck extension ì•ˆë¨! Fever, drooling.\n---\n## 8. Laryngeal Papillomatosis (í›„ë‘ ìœ ë‘ì¢…) ğŸ—£ï¸\n- **Cause:** HPV 6 & 11 (Vertical transmission).\n- **Symptom:** **Hoarseness (ì‰° ëª©ì†Œë¦¬)** in a child.\n- **Exam:** Finger-like growths on vocal cords.\n- **Treatment:** **Surgical Debridement.** (Recurrent nature).\n---\n## ğŸ”¥ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n1. **Pale/Blueish Mucosa + Sneezing:** Allergic Rhinitis (Treat: Intranasal Steroids).\n2. **Beefy Red Mucosa + No Eye Symptoms:** Non-Allergic Rhinitis (Treat: Vasomotor agents).\n3. **Septal Hematoma:** Drain immediately (Prevent saddle nose).\n4. **Midline Neck Mass (Moves with tongue):** Thyroglossal Duct Cyst (Sistrunk procedure).\n5. **Lateral Neck Mass (Anterior to SCM):** Branchial Cleft Cyst.\n6. **Violaceous Lymph Node:** Mycobacterium Avium (Excision, No I&D).\n7. **Adult with Unilateral Ear Fluid:** Nasopharyngeal Carcinoma (Check EBV).\n8. **White Patch (Can't wipe off):** Biopsy (Leukoplakia).\n9. **Stridor Worse Supine:** Laryngomalacia.\n---\n### ğŸ’¡ Provocative Final Thought\n\"ë°±ì‹ ì´ ì§ˆë³‘ì˜ ì§€í˜•ë„ë¥¼ ë°”ê¿¨ìŠµë‹ˆë‹¤. *H. influenzae* (Epiglottitis)ëŠ” ì‚¬ë¼ì§€ê³  ìˆì§€ë§Œ, ë°±ì‹  ê±°ë¶€ ìš´ë™ìœ¼ë¡œ ë‹¤ì‹œ ëŒì•„ì˜¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ìš°ë¦¬ê°€ ë°°ìš°ëŠ” 'êµê³¼ì„œì ' ì§ˆë³‘ë“¤ì€ ê³ ì •ëœ ê²ƒì´ ì•„ë‹ˆë¼ ì‚´ì•„ ì›€ì§ì´ëŠ” ìƒíƒœê³„ì…ë‹ˆë‹¤. í•­ìƒ 'Sick vs Not Sick'ì„ êµ¬ë³„í•˜ëŠ” ì§ê´€ì„ ìœ ì§€í•˜ì‹­ì‹œì˜¤.\"\n# ğŸ« USMLE Step 2 Deep Dive: ì¢…ê²©ë™ (Mediastinum) ì™„ì „ ì •ë³µ\nì´ ê°•ì˜ëŠ” USMLE Step 2 ì‹œí—˜ì„ ì¤€ë¹„í•˜ëŠ” í•™ìƒë“¤ì„ ìœ„í•´ êµ°ë”ë”ê¸°ë¥¼ ë¹¼ê³ (no fluff), ì‹œí—˜ì— ì‹¤ì œ ë“±ì¥í•˜ëŠ” ê°œë…, í•´ë¶€í•™, ê·¸ë¦¬ê³  Red Flag(ìœ„í—˜ ì‹ í˜¸)ë¥¼ ì§‘ì¤‘ì ìœ¼ë¡œ ë‹¤ë£¹ë‹ˆë‹¤. ì„ìƒì  ì¶”ë¡ (Clinical Reasoning)ì„ ì¤‘ì‹¬ìœ¼ë¡œ ì¢…ê²©ë™ ì§ˆí™˜ì„ ë§ˆìŠ¤í„°í•´ ë´…ì‹œë‹¤.\n## 1. Introduction: ìœ„ì¹˜ê°€ ê³§ ì§„ë‹¨ì´ë‹¤ (Location is Everything)\n- **í•µì‹¬ ê°œë…:** ì¢…ê²©ë™(Mediastinum)ì€ ì‹¬ì¥, ëŒ€í˜ˆê´€, ê¸°ë„, ì‹ë„ ë“±ì´ ë¹½ë¹½í•˜ê²Œ ëª¨ì—¬ ìˆëŠ” ìš°ë¦¬ ëª¸ì—ì„œ ê°€ì¥ ë³µì¡í•œ ê³µê°„ì…ë‹ˆë‹¤.\n- **ì‹œí—˜ íŒ:** ë¬¸ì œì˜ ì§€ë¬¸(Stem)ì—ì„œ ì¢…ê´´(Mass)ì˜ ìœ„ì¹˜(ì•, ì¤‘ê°„, ë’¤)ë¥¼ ì•„ëŠ” ê²ƒì´ ì§„ë‹¨ì˜ ê°€ì¥ ì¤‘ìš”í•œ ë‹¨ì„œì´ì ì§€ë„(Map)ì…ë‹ˆë‹¤.\n- **ì „ëµ:** ì¢…ê²©ë™ì„ **ì „ë°©(Anterior), ì¤‘ë°©(Middle), í›„ë°©(Posterior)** êµ¬íšìœ¼ë¡œ ë‚˜ëˆ„ì–´ ì ‘ê·¼í•©ë‹ˆë‹¤.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-252","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","treatment"]}
{"chunk_type":"transcript_chunk","text":"## 2. ì „ë°© ì¢…ê²©ë™ (Anterior Mediastinum): The \"4 Ts\"\nì „ë°© ì¢…ê²©ë™ì€ í‰ê³¨(Sternum)ê³¼ ì‹¬ì¥ ì‚¬ì´ì˜ ê³µê°„ì…ë‹ˆë‹¤. ì´ê³³ì˜ ì¢…ê´´ëŠ” **'4 Ts'**ë¡œ ê¸°ì–µí•´ì•¼ í•©ë‹ˆë‹¤.\n### ğŸš© 1. Thymoma (í‰ì„ ì¢…)\n- **ì—°ê´€ ì§ˆí™˜:** **â˜… ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ (Myasthenia Gravis)**. í‰ì„ ì¢… í™˜ìì˜ 30~50%ê°€ ì¤‘ì¦ê·¼ë¬´ë ¥ì¦ì„ ë™ë°˜í•©ë‹ˆë‹¤.\n- **ì„ìƒ ì‹œë‚˜ë¦¬ì˜¤:** ì „ë°© ì¢…ê´´ + ì•ˆê²€í•˜ìˆ˜(Ptosis) ë˜ëŠ” í•˜ë£¨ ì¤‘ ì‹¬í•´ì§€ëŠ” ê·¼ë ¥ ì•½í™”.\n- **ì¶”ê°€ ì—°ê´€ì„±:** ìˆœìˆ˜ ì í˜ˆêµ¬ ë¬´í˜•ì„±ì¦(Pure red cell aplasia)ê³¼ë„ ì—°ê´€ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n### ğŸš© 2. Thyroid Neoplasm (ê°‘ìƒì„  ì¢…ì–‘)\n- **íŠ¹ì§•:** ì¼ë°˜ì ì¸ ëª©ì˜ ê²°ì ˆì´ ì•„ë‹Œ, í‰ê³½ ë‚´ë¡œ ìë¼ ë‚´ë ¤ì˜¨ **í‰ê³¨í•˜ ê°‘ìƒì„ ì¢…(Substernal Goiter)**ì…ë‹ˆë‹¤.\n- **ì˜ìƒ ì†Œê²¬:** ì—‘ìŠ¤ë ˆì´ìƒ ê¸°ê´€(Trachea)ì´ ì˜†ìœ¼ë¡œ ë°€ë¦° ì†Œê²¬(Deviation)ì´ í”í•©ë‹ˆë‹¤.\n- **ì¦ìƒ:** ì••ë°• ì¦ìƒ (ì‚¼í‚´ ê³¤ë€, í˜‘ì°©ìŒ ë“±).\n- **â˜… Pemberton's Sign (í¨ë²„íŠ¼ ì§•í›„):**\n    - í™˜ìì—ê²Œ ì–‘íŒ”ì„ ë¨¸ë¦¬ ìœ„ë¡œ ë“¤ê²Œ í–ˆì„ ë•Œ, í‰ê³¨í•˜ ê°‘ìƒì„ ì¢…ì´ í‰ê³½ ì…êµ¬ë¥¼ ë§‰ì•„ ì¼ì‹œì ì¸ **ìƒëŒ€ì •ë§¥ ì¦í›„êµ°(SVC syndrome)**ì„ ìœ ë°œí•©ë‹ˆë‹¤.\n    - ì–¼êµ´ì´ ë¶‰ì–´ì§€ê³ (Flushed), ëª©ì˜ ì •ë§¥ì´ í™•ì¥ë©ë‹ˆë‹¤.\n### ğŸš© 3. Teratoma (ê¸°í˜•ì¢…) & Germ Cell Tumors\n- **ëŒ€ìƒ:** ì Šì€ ì„±ì¸ (ì£¼ë¡œ 15~35ì„¸ ë‚¨ì„±).\n- **ì¢…ë¥˜:**\n    - **Teratoma:** ì¹˜ì•„ë‚˜ ë¨¸ë¦¬ì¹´ë½ ë“±ì„ í¬í•¨.\n    - **Seminoma (ì •ìƒí”¼ì¢…) & Non-seminoma.**\n- **ì§„ë‹¨ ë§ˆì»¤ (Biomarkers):** ì Šì€ ë‚¨ì„±ì—ê²Œ ì „ë°© ì¢…ê´´ê°€ ìˆë‹¤ë©´ ë°˜ë“œì‹œ í™•ì¸í•´ì•¼ í•©ë‹ˆë‹¤.\n    - **Non-seminoma:** Beta-HCGì™€ AFP ë‘˜ ë‹¤ ìƒìŠ¹.\n    - **Seminoma:** ì£¼ë¡œ Beta-HCGë§Œ ìƒìŠ¹ (AFPëŠ” ìƒìŠ¹í•˜ì§€ ì•ŠìŒ).\n### ğŸš© 4. \"Terrible\" Lymphoma (ë¦¼í”„ì¢…)\n- **ì£¼ì˜ì :** ë¦¼í”„ì¢…(íŠ¹íˆ í˜¸ì§€í‚¨ ë¦¼í”„ì¢…, ì Šì€ ì—¬ì„±)ì´ ì „ë°© ì¢…ê²©ë™ì— ìƒê¸¸ ìˆ˜ ìˆì§€ë§Œ, ë¦¼í”„ì ˆì€ ì–´ë””ì—ë‚˜ ìˆìœ¼ë¯€ë¡œ **â˜… ë¦¼í”„ì¢…ì€ ì „ë°©, ì¤‘ë°©, í›„ë°© ì–´ë””ì„œë“  ë°œìƒí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.** (\"Tunnel vision\"ì„ ê°–ì§€ ë§ ê²ƒ!)\n### ğŸ’¡ í‰ì„ (Thymus)ì— ëŒ€í•œ ì¤‘ìš”í•œ ë‚˜ì´ë³„ ê·œì¹™\n| êµ¬ë¶„ | ì‹ ìƒì•„/ì˜ì•„ (<3ì„¸) | ì„±ì¸ |\n| --- | --- | --- |\n| **ì •ìƒ ì†Œê²¬** | **Thymic Sail Sign** (ê±°ëŒ€í•œ ì‚¼ê°í˜• ê·¸ë¦¼ì)ì€ ì •ìƒ ìƒë¦¬ì  ì†Œê²¬ì„. | í‰ì„ ì€ ìœ„ì¶•ë˜ì–´ ì§€ë°©ìœ¼ë¡œ ë³€í•¨. ì—‘ìŠ¤ë ˆì´ì—ì„œ ë³´ì´ë©´ ì•ˆ ë¨. |\n| **ë³‘ì  ì†Œê²¬** | **â˜… ê·¸ë¦¼ìê°€ ì—†ëŠ” ê²½ìš°:** ë©´ì—­ ê²°í• ì˜ì‹¬ (DiGeorge Syndrome, SCID). | **â˜… ìŒì˜ì´ ë³´ì´ëŠ” ê²½ìš°:** ë¬´ì¡°ê±´ ë³‘ì ì„ (Thymoma, Lymphoma, Germ cell tumor ë“±). ì •ë°€ ê²€ì‚¬ í•„ìš”. |\n---\n## 3. ì¤‘ë°© ì¢…ê²©ë™ (Middle Mediastinum): The Busy Center\nì‹¬ì¥, ì‹¬ë§‰(Pericardium), ëŒ€ë™ë§¥, ê¸°ë„, ì‹ë„, ê·¸ë¦¬ê³  **ë¦¼í”„ì ˆ(Lymph nodes)**ì´ ì¡´ì¬í•˜ëŠ” ë‚´ì¥ ê³µê°„(Visceral space)ì…ë‹ˆë‹¤.\n- **â˜… ë¦¼í”„ì ˆ ë¹„ëŒ€ (Lymphadenopathy):**\n    - ê°€ì¥ ë¨¼ì € ë– ì˜¬ë ¤ì•¼ í•  ì§ˆí™˜: **Sarcoidosis (ì‚¬ë¥´ì½”ì´ë“œì¦)**.\n    - **ì „í˜•ì  ì¦ìƒ:** í‘ì¸ ì—¬ì„±, ê¸°ì¹¨, **ì–‘ì¸¡ íë¬¸ ë¦¼í”„ì ˆ ë¹„ëŒ€(Bilateral Hilar Lymphadenopathy)**.\n    - ê¸°íƒ€ ì›ì¸: íì•” ì „ì´, ì§„ê·  ê°ì—¼ ë“±.\n- **ë‚­ì¢… (Cysts):**\n    - **Bronchogenic cyst:** ê¸°ë„ì˜ ë°œë‹¬ ì´ìƒ.\n    - **Pericardial cyst:** ì‹¬ë§‰ì— ë¶™ì€ ì•¡ì²´ ì£¼ë¨¸ë‹ˆ (ì£¼ë¡œ ìš°ì—°íˆ ë°œê²¬).\n- **í˜ˆê´€ ë° ì‹ë„:** ëŒ€ë™ë§¥ê¶ ë™ë§¥ë¥˜(Aortic arch aneurysm), ì‹ë„ë‚˜ ê¸°ë„ì˜ ì¢…ì–‘.\n---\n## 4. í›„ë°© ì¢…ê²©ë™ (Posterior Mediastinum): Neuro Focus\nì²™ì¶”, êµê°ì‹ ê²½ì‚¬ìŠ¬(Sympathetic chain), ì²™ì¶”ì—ì„œ ë‚˜ì˜¤ëŠ” ì‹ ê²½ë“¤ì´ ìœ„ì¹˜í•œ ê³³ì…ë‹ˆë‹¤.\n- **í•µì‹¬ í…Œë§ˆ:** **â˜… ì‹ ê²½ (Neuro)**.\n- **ê°€ì¥ í”í•œ ì§„ë‹¨:** **Neurogenic tumor (ì‹ ê²½ì¸ì„± ì¢…ì–‘)**.\n    - Schwannoma (ì‹ ê²½ì´ˆì¢…), Neurofibroma (ì‹ ê²½ì„¬ìœ ì¢…).\n- **â˜… ë¤ë²¨ ì¢…ì–‘ (Dumbbell Tumor):**\n    - ì¢…ì–‘ì´ ì¶”ê°„ê³µ(Intervertebral foramen)ì„ í†µí•´ ìë¼ë‚˜ì„œ, ì¼ë¶€ëŠ” ì²™ì¶”ê´€ì—, ì¼ë¶€ëŠ” ì¢…ê²©ë™ì— ìœ„ì¹˜í•˜ì—¬ ë¤ë²¨ ëª¨ì–‘ì„ í˜•ì„±í•©ë‹ˆë‹¤.\n- **ê¸°íƒ€ ì›ì¸:** ì²™ì¶” ì „ì´(Spinal mets), ìˆ˜ë§‰ë¥˜(Meningocele), ë¦¼í”„ì¢…(ì¹´ë©œë ˆì˜¨ì²˜ëŸ¼ ì–´ë””ë“  ì¡´ì¬ ê°€ëŠ¥), ì‹ë„ ì—´ê³µ íƒˆì¥(Hiatus hernia - ì‹¬ì¥ ë’¤ì— ê±°ëŒ€í•œ ê³µê¸° ë°©ìš¸ì´ ë³´ì„).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-272","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"---\n## 5. ê¸‰ì„± ì¢…ê²©ë™ì—¼ (Acute Mediastinitis): ì‘ê¸‰ ìƒí™© ğŸš¨\nì ˆëŒ€ë¡œ ë†“ì³ì„œëŠ” ì•ˆ ë˜ëŠ” ì¹˜ëª…ì ì¸ ê´´ì‚¬ì„± ê°ì—¼ì…ë‹ˆë‹¤.\n### ì„ìƒ ì–‘ìƒ\n- **ì¦ìƒ:** ë§¤ìš° ìœ„ë…í•´ ë³´ì„(Toxic), ê³ ì—´, ë¹ˆë§¥, ì‹¬í•œ í‰ê³¨ ë’¤ í†µì¦(Retrosternal chest pain).\n- **ì˜ìƒ:** ì¢…ê²©ë™ í™•ì¥ (Mediastinal widening).\n### ì£¼ìš” ì›ì¸ 2ê°€ì§€\n1. **ìˆ˜ìˆ  í›„ (Post-operative):**\n    - ì‹¬ì¥ ìˆ˜ìˆ (Sternotomy) í›„ ì•½ 2ì£¼ ë’¤, í™˜ìê°€ íšŒë³µë˜ëŠ” ë“¯í•˜ë‹¤ê°€ ê°‘ìê¸° ê³ ì—´ì´ ë‚˜ê³  ìˆ˜ìˆ  ë¶€ìœ„ê°€ ë¶ˆì•ˆì •í•´ì§.\n    - **ì¹˜ë£Œ (Triad):** **â˜… ë°°ë†(Drainage), ë³€ì—°ì ˆì œ(Debridement), í•­ìƒì œ(Antibiotics).** ì¦‰ì‹œ ìˆ˜ìˆ ì‹¤ë¡œ ë³µê·€í•´ì•¼ í•¨.\n2. **ì¸ì ‘ ë¶€ìœ„ í™•ì‚° (Contiguous Spread) - â˜… Danger Space:**\n    - **ìœ„í—˜ ê³µê°„(Danger Space):** ë‘ê°œì €(Base of skull)ë¶€í„° íš¡ê²©ë§‰ê¹Œì§€ ì´ì–´ì§€ëŠ” ê¹Šì€ ëª© ê·¼ë§‰(Deep neck fascia) ì‚¬ì´ì˜ ê³µê°„. 'ê°ì—¼ì˜ ê³ ì†ë„ë¡œ'.\n    - **ì‹œë‚˜ë¦¬ì˜¤:** ì¸ë‘ë’¤ë†ì–‘(Retropharyngeal abscess)ì´ë‚˜ ì¹˜ê³¼ ê°ì—¼ì´ ì¤‘ë ¥ì— ì˜í•´ ì´ ê³µê°„ì„ íƒ€ê³  ë‚´ë ¤ì™€ **ê¸‰ì„± ê´´ì‚¬ì„± ì¢…ê²©ë™ì—¼**ì„ ìœ ë°œ.\n    - **ì¹˜ë£Œ:** ê¸°ë„ í™•ë³´(Airway first!) â†’ ìˆ˜ìˆ ì  ë°°ë†(ëª©+í‰ë¶€) â†’ ê´‘ë²”ìœ„ í•­ìƒì œ(í˜ê¸°ì„± ê·  ì»¤ë²„).\n---\n## 6. ê¸°ì¢…ê²©ë™ (Pneumomediastinum)\n- **ìœ í˜•:** ìë°œì„± ê¸°ì¢…ê²©ë™ (Spontaneous Pneumomediastinum).\n- **í™˜ì í”„ë¡œí•„:** í‚¤ê°€ í¬ê³  ë§ˆë¥¸ ì²­ì†Œë…„ê¸° ë‚¨ì„±.\n- **ìœ ë°œ ìš”ì¸:** ë°œì‚´ë°”(Valsalva) ì¡°ì‘ (ê¸°ì¹¨, êµ¬í† , í˜ì£¼ê¸° ë“±) í›„ ê°‘ì‘ìŠ¤ëŸ¬ìš´ í‰í†µ ë°œìƒ.\n- **â˜… Hammond's Sign:**\n    - ì²­ì§„ ì‹œ ì‹¬ì¥ ë°•ë™ì— ë§ì¶° **'ë°”ìŠ¤ë½'ê±°ë¦¬ê±°ë‚˜ 'í´ë¦­'í•˜ëŠ” ì†Œë¦¬(Crunching/Clicking)**ê°€ ë“¤ë¦¼. (ì‹¬ì¥ì´ ê³µê¸° ì£¼ë¨¸ë‹ˆë¥¼ ë•Œë¦¬ëŠ” ì†Œë¦¬).\n- **ì˜ˆí›„ ë° ì¹˜ë£Œ:**\n    - ì‹ë„ íŒŒì—´(Esophageal rupture)ì„ ë°°ì œí•œë‹¤ë©´, ëŒ€ë¶€ë¶„ **ì–‘ì„±(Benign)** ê²½ê³¼.\n    - **ì¹˜ë£Œ:** íœ´ì‹, í†µì¦ ì¡°ì ˆ, ë°œì‚´ë°” í”¼í•˜ê¸°. ê³¼ì‰ ì¹˜ë£Œ ê¸ˆì§€(Don't overtreat). ê³µê¸°ëŠ” ì €ì ˆë¡œ í¡ìˆ˜ë¨.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-292","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core"]}
{"chunk_type":"recap_summary","text":"## 7. âš¡ Rapid Fire Recap (í•µì‹¬ ìš”ì•½)\n| êµ¬íš | ì£¼ìš” ì§ˆí™˜ ë° íŠ¹ì§• |\n| --- | --- |\n| **ì „ë°© (Anterior)** | **4 Ts:** Thymoma(ì¤‘ì¦ê·¼ë¬´ë ¥ì¦), Thyroid(Pemberton's sign), Teratoma(Germ cell), Terrible Lymphoma.\n**Thymus:** ì†Œì•„ëŠ” í¼(ì •ìƒ- no: Digeorge, SCID ), ì„±ì¸ì€ ì•ˆ ë³´ì—¬ì•¼ ì •ìƒ-ìˆìœ¼ë©´ bx. |\n| **ì¤‘ë°© (Middle)** | **ë¦¼í”„ì ˆ & ë‚­ì¢…:** Sarcoidosis(ì–‘ì¸¡ íë¬¸ ë¦¼í”„ì ˆ), Bronchogenic cysts. |\n| **í›„ë°© (Posterior)** | **ì‹ ê²½(Neuro):** Neurogenic tumors (Dumbbell shape). |\n| **ê¸‰ì„± ì¢…ê²©ë™ì—¼** | ìˆ˜ìˆ  í›„ ë˜ëŠ” Danger spaceë¥¼ í†µí•œ ê°ì—¼ í™•ì‚°. **ì¦‰ê°ì ì¸ ìˆ˜ìˆ ì  ë°°ë† í•„ìš”.** |\n| **ê¸°ì¢…ê²©ë™** | í‚¤ í¬ê³  ë§ˆë¥¸ ì†Œë…„ + ë°œì‚´ë°” + **Hammond's sign**. íœ´ì‹ìœ¼ë¡œ ì¹˜ë£Œ. |\n---\n## 8. ë§ˆì§€ë§‰ ì„ìƒ ì§„ì£¼ (Clinical Pearl): Clubbing & COPD ğŸ’\n- **ìƒí™©:** ì‹ ì²´ ê²€ì§„ì—ì„œ **ê³¤ë´‰ì§€(Digital Clubbing)**ê°€ ê´€ì°°ë¨.\n- **í”í•œ ì˜¤í•´:** ë§ì€ í•™ìƒë“¤ì´ ê³¤ë´‰ì§€ë¥¼ COPD(ë§Œì„±íì‡„ì„±íì§ˆí™˜)ì™€ ë°”ë¡œ ì—°ê²°ì§€ìŒ.\n- **â˜… íŒ©íŠ¸ ì²´í¬:** í•©ë³‘ì¦ì´ ì—†ëŠ” ë‹¨ìˆœ COPDëŠ” ê³¤ë´‰ì§€ë¥¼ ìœ ë°œí•˜ì§€ ì•ŠìŒ.\n- **Red Flag:** ë§Œì•½ ë§Œì„± COPD í™˜ìê°€ **ìƒˆë¡œìš´ ê³¤ë´‰ì§€**ë¥¼ ë³´ì¸ë‹¤ë©´?\n    - ë‹¨ìˆœíˆ COPD ë•Œë¬¸ì´ë¼ê³  ì¹˜ë¶€í•˜ë©´ ì•ˆ ë¨.\n    - **ìˆ¨ê²¨ì§„ ì•…ì„± ì¢…ì–‘(Occult Malignancy)**, íŠ¹íˆ **â˜… íì•”(Bronchogenic Carcinoma)**ì„ ì¦‰ì‹œ ì˜ì‹¬í•´ì•¼ í•¨.\n    - **í–‰ë™ ì§€ì¹¨:** ì¦‰ì‹œ CT ì´¬ì˜ ë“± ì •ë°€ ê²€ì‚¬ ì§„í–‰.\n# ğŸ« Obstructive Lung Disease: Battle Strategy âš”ï¸\nUSMLE Step 2ëŠ” ëª¨í˜¸í•œ ê²ƒì„ ì‹«ì–´í•©ë‹ˆë‹¤. **Binary(ì´ë¶„ë²•)**ì ì¸ ê²°ì •ì´ ìƒëª…ì…ë‹ˆë‹¤! âš–ï¸\nì˜¤ëŠ˜ì˜ ë¯¸ì…˜ì€ **Acute Bronchitis(í•¨ì •)**ì™€ **COPD(ê´´ë¬¼)**ë¥¼ ì •ë³µí•˜ëŠ” ê²ƒì…ë‹ˆë‹¤.\n---\n### 1. ğŸ¦  Acute Bronchitis (ê¸‰ì„± ê¸°ê´€ì§€ì—¼) : The Trap ğŸª¤","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-303","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","recap"]}
{"chunk_type":"transcript_chunk","text":"ì‹œí—˜ì—ì„œ ê°€ì¥ í”íˆ íŒŒëŠ” í•¨ì •ì…ë‹ˆë‹¤. \"í•­ìƒì œë¥¼ ì¤„ ê²ƒì¸ê°€ ë§ ê²ƒì¸ê°€?\"\n- **ì •ì˜ & ì›ì¸**: ëŒ€ê¸°ë„(Large airways)ì˜ ì—¼ì¦.\n    - â˜… **90% Viral** ğŸ¦ : Influenza, Rhinovirus ë“±. (BacteriaëŠ” ê±°ì˜ ì—†ìŒ! ğŸ™…â€â™‚ï¸)\n- **ì¦ìƒ ê¸°ê°„ ğŸ—“ï¸**: ê¸°ì¹¨ì€ **5ì¼ ~ 3ì£¼(3 weeks)**ê¹Œì§€ ê°ˆ ìˆ˜ ìˆìŒ.\n    - âš ï¸ **Trap**: 3ì£¼ ë™ì•ˆ ê¸°ì¹¨í•œë‹¤ê³  íë ´(Pneumonia)ì´ ì•„ë‹™ë‹ˆë‹¤!\n- **ì§„ë‹¨ (Diagnosis) ğŸ©º**:\n    - **Clinical Diagnosis**: ì„ìƒì ìœ¼ë¡œ ì§„ë‹¨í•¨.\n    - **No Systemic Signs**: ê³ ì—´(High fever) ğŸŒ¡ï¸, ì˜¤í•œ(Chills) ğŸ¥¶, ê²½ì§(Rigors) âŒ.\n    - **Lung Exam**: Wheezing(ìŒ•ìŒ•ê±°ë¦¼)ì€ OK, í•˜ì§€ë§Œ **Crackles(ì•…ì„¤ìŒ)**ì€ ì—†ì–´ì•¼ í•¨. ğŸ”‡\n    - **CXR?** ğŸ“¸: **No!** í™œë ¥ ì§•í›„ê°€ ì•ˆì •ì ì´ë©´ ì°ì§€ ë§ˆì„¸ìš”.\n- **ì¹˜ë£Œ (Treatment) ğŸ’Š**:\n    - ì˜¤ì§ **Symptom Control**: ì§„í†µì œ(NSAIDs), ê¸°ê´€ì§€ í™•ì¥ì œ.\n    - â˜… **No Antibiotics** ğŸš«: í™˜ìê°€ ì• ì›í•´ë„ í•­ìƒì œ ì£¼ë©´ ì‹œí—˜ì—ì„œ ê°ì ì…ë‹ˆë‹¤!\n---\n### 2. ğŸš¬ COPD: The Beast ğŸ¦\nCOPDëŠ” ë‘ ê°€ì§€ ë³‘íƒœìƒë¦¬ë¥¼ í¬í•¨í•˜ëŠ” **ìš°ì‚°(Umbrella) â˜‚ï¸** ê°™ì€ ê°œë…ì…ë‹ˆë‹¤.\n### A. Pathophysiology âš™ï¸\n1. **Chronic Bronchitis (ë§Œì„± ê¸°ê´€ì§€ì—¼)** ğŸš°:\n    - **\"Clogged, Wet Plumbing\"**: ë°°ê´€ì´ ë§‰íˆê³  ì –ì–´ ìˆìŒ.\n    - Goblet cell ê³¼ë‹¤ ë¶„ë¹„ â†’ ê°€ë˜(Mucus) ì½¸ì½¸ ğŸ¤®\n2. **Emphysema (íê¸°ì¢…)** ğŸˆ:\n    - **\"Old Balloon\"**: í—Œ í’ì„ ì²˜ëŸ¼ íƒ„ì„±(Elastic recoil)ì„ ìƒìŒ.\n    - ê³µê¸°ê°€ ë“¤ì–´ì˜¤ê¸´ í•˜ëŠ”ë° ë‚˜ê°€ì§€ ëª»í•¨ (**Air Trapping**) ğŸ“¦\n### B. Diagnosis (Gold Standard) ğŸ†\n- **Spirometry**: â˜… **FEV1/FVC < 0.7** ğŸ“‰\n- **Irreversible**: ê¸°ê´€ì§€ í™•ì¥ì œë¥¼ ì¨ë„ ëŒì•„ì˜¤ì§€ ì•ŠìŒ. (ì²œì‹ê³¼ ë‹¤ë¦„ â†”ï¸)\n- **Loop ëª¨ì–‘**: **\"Scooped out sail\"** (í‘¹ êº¼ì§„ ë›ë‹¨ë°° ëª¨ì–‘ â›µ)\n### C. Emphysema vs. Chronic Bronchitis êµ¬ë¶„ë²•: DLCO ğŸŒ¬ï¸\n- **Emphysema**: ë²½ì´ íŒŒê´´ë¨ ğŸšï¸ â†’ í‘œë©´ì  ê°ì†Œ â†’ **Low DLCO** â¬‡ï¸\n- **Chronic Bronchitis**: íí¬(Alveoli)ëŠ” ë©€ì©¡í•¨ âœ¨ â†’ **Normal DLCO** â¡ï¸\n    - *Tip*: íì‡„ì„± íŒ¨í„´ì¸ë° DLCOê°€ ë‚®ë‹¤? â†’ Emphysema!\n---\n### 3. ğŸš¨ COPD Exacerbation (ê¸‰ì„± ì•…í™”) : Emergency Room ğŸ¥\nì‘ê¸‰ì‹¤ì—ì„œ ìˆ¨ì´ ì°¨ì„œ ì˜¨ í™˜ì, **COPDì¸ê°€ ì‹¬ë¶€ì „(CHF)ì¸ê°€?** ì´ê²ƒì´ ë¬¸ì œì…ë‹ˆë‹¤. ğŸ¤”\n### A. The Classic Differential: ABG is King ğŸ‘‘\në‘ ì§ˆí™˜ ëª¨ë‘ ìŒ•ìŒ•ê±°ë¦´(Wheezing) ìˆ˜ ìˆìŠµë‹ˆë‹¤. êµ¬ë¶„ì€ **ê°€ìŠ¤(Gas)**ë¡œ í•©ë‹ˆë‹¤.\n| **Feature** | **ğŸš¬ COPD Exacerbation** | **ğŸ’” CHF (Heart Failure)** |\n| --- | --- | --- |\n| **ë¬¸ì œì ** | Air Trapping (ê³µê¸°ê°€ ê°‡í˜) ğŸ“¦ | Wet Lungs (ë¬¼ì— ì ê¹€) ğŸŒŠ |\n| **í™˜ê¸°** | CO2 Retain (ì´ì‚°í™”íƒ„ì†Œ ì €ë¥˜) â¬†ï¸ | Hyperventilate (ê³¼í˜¸í¡) ğŸŒ¬ï¸ |\n| **â˜… ABG** | **Respiratory Acidosis** (High CO2) ğŸ”´ | **Respiratory Alkalosis** (Low CO2) ğŸ”µ |\n| **Sound** | Wheezing ğŸ¶ | Crackles ğŸ¿ |\n### B. Treatment Steps (ìˆœì„œ ì¤‘ìš”!) 1ï¸âƒ£2ï¸âƒ£3ï¸âƒ£\n1. **Oxygen ğŸ…¾ï¸**:\n    - Target SpO2: **88 ~ 92%** ğŸ¯ (100% ì£¼ë©´ CO2 í˜¼ìˆ˜ ì™€ì„œ í°ì¼ ë‚¨ â˜ ï¸)\n2. **Meds ğŸ’Š**:\n    - Inhaled Bronchodilators (Albuterol + Ipratropium = Duoneb) ğŸ’¨\n    - â˜… **Systemic Steroids**: **Oral Prednisone** or IV. (í¡ì…ì œ ì•„ë‹˜! ì „ì‹  ìŠ¤í…Œë¡œì´ë“œ í•„ìˆ˜ ğŸ’ª)\n3. **Antibiotics ğŸ¦ **:\n    - ë¬´ì¡°ê±´ ì£¼ëŠ” ê±° ì•„ë‹˜! ğŸ™…\n    - **3 Cardinal Symptoms**: Dyspnea, Sputum Volume, **Sputum Purulence(ëˆ„ëŸ° ê°€ë˜)**.\n    - Rule: 2ê°€ì§€ ì¦ìƒ + ê·¸ì¤‘ í•˜ë‚˜ê°€ **Purulence**ì¼ ë•Œ íˆ¬ì—¬.\n4. **NIPPV (BiPAP) ğŸ­**:\n    - ì‚°ì¦(Acidosis)ì´ ê³„ì†ë˜ë©´ ì‚½ê´€(Intubation) ì „ì— ë¬´ì¡°ê±´ ì‹œë„!\n    - \"Blow off CO2\" ğŸŒ¬ï¸ â†’ ì‚½ê´€ì„ ë§‰ì•„ì£¼ëŠ” êµ¬ì„¸ì£¼.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-313","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"### 4. ğŸ›Œ Chronic Management (ë§Œì„± ê´€ë¦¬) : Long Game ğŸ¢\n\"í™˜ìë¥¼ ë” ì˜¤ë˜ ì‚´ê²Œ í•˜ëŠ” ê²ƒì€?\" (Mortality Benefit) ğŸ’€ğŸ“‰\n### A. Mortality Benefit (ìƒì¡´ìœ¨ ì¦ê°€) ğŸŒŸ\nì •ë‹µì€ ë”± ë‘ ê°œë¿ì…ë‹ˆë‹¤!\n1. **Smoking Cessation (ê¸ˆì—°)** ğŸš­: ë¬´ì¡°ê±´ 1ìˆœìœ„.\n2. **Long-term Oxygen (ì¬íƒ ì‚°ì†Œ)** ğŸ :\n    - í•˜ë£¨ 15ì‹œê°„ ì´ìƒ ì‚¬ìš©. ğŸ•’\n    - **Cutoff**: PaO2 â‰¤ 55 or SaO2 â‰¤ 88%. (ìš°ì‹¬ë¶€ì „ ìˆìœ¼ë©´ 59/89%)\n### B. Symptom Control (ì¦ìƒ ì™„í™”) ğŸ˜Œ\n- **LAMA > LABA**: ë¯¸ì£¼ì‹ ê²½(Vagal tone)ì´ ì¤‘ìš”í•˜ë¯€ë¡œ **LAMA(Tiotropium)**ê°€ First-line. ğŸ¥‡\n- **Inhaled Steroids (ICS)**: COPDì—ì„œëŠ” **Add-on**ì¼ ë¿, ë‹¨ë… ì‚¬ìš© ê¸ˆì§€ âŒ. (ì²œì‹ê³¼ë°˜ëŒ€! â˜… )\n---\n### 5. ğŸ”¥ Rapid Fire Recap (Summary) ğŸ”¥\nê°•ì˜ ë§ˆì§€ë§‰ì— ì •ë¦¬ëœ ë‚´ìš©ì„ ê·¸ëŒ€ë¡œ ë°›ì•„ì ì—ˆìŠµë‹ˆë‹¤. (ì‹œí—˜ ì§ì „ ë³µìŠµìš©!)\n- **Acute Bronchitis (ê¸‰ì„± ê¸°ê´€ì§€ì—¼)** ğŸ¦ :\n    - Viral(ë°”ì´ëŸ¬ìŠ¤ì„±)ì´ë‹¤.\n    - ê¸°ì¹¨ì€ 3ì£¼ ë¯¸ë§Œ.\n    - ì—´(Fever) ì—†ìŒ.\n    - **No Antibiotics (í•­ìƒì œ ê¸ˆì§€)!** ğŸ›‘\n- **COPD Diagnosis (ì§„ë‹¨)** ğŸ“Š:\n    - FEV1/FVC < 0.7.\n    - Irreversible (ë¹„ê°€ì—­ì ).\n    - Scooped out loop (í‘¹ êº¼ì§„ ê³¡ì„ ). ğŸ“‰\n- **Emphysema vs. Chronic Bronchitis** ğŸ†š:\n    - **DLCO**ë¡œ êµ¬ë¶„.\n    - Low DLCO = Emphysema (íê¸°ì¢…).\n    - Normal DLCO = Chronic Bronchitis (ë§Œì„± ê¸°ê´€ì§€ì—¼).\n- **COPD Exacerbation Differential (ê°ë³„ ì§„ë‹¨)** âš–ï¸:\n    - Acidosis (High CO2) = **COPD**. ğŸš¬\n    - Alkalosis (Low CO2) = **CHF**. ğŸ’”\n- **Exacerbation Management (ì•…í™” ì¹˜ë£Œ)** ğŸ› ï¸:\n    - Oxygen target **88-92%**. ğŸ¯\n    - Bronchodilators (ê¸°ê´€ì§€ í™•ì¥ì œ).\n    - **Systemic** Steroids (ì „ì‹  ìŠ¤í…Œë¡œì´ë“œ).\n    - Antibiotics (ê°€ë˜ê°€ ëˆ„ëŸ´ ë•Œë§Œ/Purulent). ğŸŸ¡\n    - **BiPAP** (ì‚°ì¦/Acidosisì¼ ë•Œ). ğŸ­\n- **Mortality Benefit (ì‚¬ë§ë¥  ê°ì†Œ)** ğŸ’€â¬‡ï¸:\n    - **Stop Smoking (ê¸ˆì—°)**. ğŸš­\n    - Oxygen (ì‚°ì†Œí¬í™”ë„ 88% ë¯¸ë§Œì¼ ë•Œ). ğŸ…¾ï¸\n- **Bonus Curveball: Asthma-COPD Overlap** âš¾:\n    - í¡ì—°ìì¸ë° ì²œì‹ íŠ¹ì§•(Eosinophils ë“±)ì´ ë³´ì´ë©´?\n    - ìƒì ë°–ì—ì„œ ìƒê°í•˜ì„¸ìš”! **Inhaled Steroids(ICS)**ë¥¼ ë” ì¼ì° ì“°ëŠ” ê²ƒì´ ì •ë‹µì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. âœ¨\n---\n# ğŸ« USMLE Deep Dive: Asthma & Obstructive Lung Diseases\n**Topic:** Asthma, Status Asthmaticus, Look-alikes (Bronchiectasis, ABPA)\n## ğŸŒ³ The Big Picture: Diagnosis Tree\nê°•ì˜ ì‹œì‘ ì „, ë¨¸ë¦¿ì†ì— ì§€ë„ë¥¼ ê·¸ë ¤ë´…ì‹œë‹¤.\nPlaintext\n`Obstructive Lung Disease (FEV1/FVC < 0.7)\nâ”‚\nâ”œâ”€â”€ Asthma (ê°€ì—­ì  Reversible)\nâ”‚   â”œâ”€â”€ Diagnosis: Methacholine Challenge (Rule out), Bronchodilator test\nâ”‚   â”œâ”€â”€ Emergency: Status Asthmaticus (\"Silent Chest\", Normal PCO2 is BAD)\nâ”‚   â””â”€â”€ Variants: Exercise-induced, Pregnancy\nâ”‚\nâ””â”€â”€ Differential Diagnosis (The Look-alikes)\n    â”œâ”€â”€ COPD (ë¹„ê°€ì—­ì , Low DLCO in Emphysema)\n    â”œâ”€â”€ Bronchiectasis (Structural damage, \"Cupfuls of sputum\")\n    â””â”€â”€ ABPA (Allergic reaction, High IgE, Brown mucus)`\n---\n## 1. Pathophysiology & Diagnosis Basics","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-333","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"ì²œì‹(Asthma)ì€ ê¸°ë³¸ì ìœ¼ë¡œ **\"ê¸°ë„(Airway)ì˜ ë¬¸ì œ\"**ì´ì§€ íí¬(Alveoli)ì˜ ë¬¸ì œê°€ ì•„ë‹™ë‹ˆë‹¤.\n- **Core Concept:** **\"Roach Motel\"** í˜„ìƒ. ê³µê¸°ê°€ ë“¤ì–´ì˜¬ ìˆ˜ëŠ” ìˆì§€ë§Œ(Inspiration OK), ë‚˜ê°ˆ ìˆ˜ê°€ ì—†ìŠµë‹ˆë‹¤(Expiration blocked).\n    - ì´ìœ : ì—¼ì¦(Inflammation)ê³¼ í‰í™œê·¼ ìˆ˜ì¶•(Smooth muscle constriction)ìœ¼ë¡œ ê¸°ë„ê°€ ì¢ì•„ì§€ê¸° ë•Œë¬¸ì…ë‹ˆë‹¤.\n- **Spirometry (PFT) Criteria:**\n    - **Obstruction:** FEV1/FVC ratio < 0.7 (70%).\n    - **Reversibility (The Key Differentiator):** ê¸°ê´€ì§€ í™•ì¥ì œ(Bronchodilator) íˆ¬ì—¬ í›„ FEV1ì´ **12% ì´ìƒ AND 200ml ì´ìƒ** ì¦ê°€í•˜ë©´ ì²œì‹ìœ¼ë¡œ í™•ì§„í•©ë‹ˆë‹¤.\n- **Methacholine Challenge Test:**\n    - ì–¸ì œ ì“°ëŠ”ê°€? í™˜ìê°€ ì¦ìƒì€ í˜¸ì†Œí•˜ëŠ”ë° ë³‘ì›ì—ì„œ PFTë¥¼ ì°ìœ¼ë‹ˆ **ì •ìƒ(Normal)**ì¼ ë•Œ.\n    - ì›ë¦¬: ê¸°ë„ë¥¼ ìê·¹í•˜ì—¬ ì¼ë¶€ëŸ¬ ìˆ˜ì¶•ì‹œí‚´ (Provocation). FEV1ì´ 20% ì´ìƒ ë–¨ì–´ì§€ë©´ ì–‘ì„±.\n    - **High Yield Point:** ì´ ê²€ì‚¬ëŠ” **Negative Predictive Value(ìŒì„± ì˜ˆì¸¡ë„)**ê°€ ë§¤ìš° ë†’ìŠµë‹ˆë‹¤. ì¦‰, ê²°ê³¼ê°€ ìŒì„±ì´ë©´ \"ì²œì‹ì´ ì ˆëŒ€ ì•„ë‹ˆë‹¤\"ë¼ê³  ë°°ì œ(Rule out)í•˜ëŠ” ë° ì“°ì…ë‹ˆë‹¤.\n### ğŸ“Š Visuals: Flow-Volume Loop & DLCO\nì‹œí—˜ ë¬¸ì œì— ê·¸ë¦¼ì´ë‚˜ ìˆ˜ì¹˜ë§Œ ëœë  ë‚˜ì˜¬ ë•Œë¥¼ ëŒ€ë¹„í•˜ì„¸ìš”.\n1. **Flow-Volume Loop:**\n    - **Asthma/COPD:** í˜¸ê¸°(Expiration) ê³¡ì„ ì´ ì•„ì´ìŠ¤í¬ë¦¼ ìŠ¤ì¿±ìœ¼ë¡œ íŒŒë‚¸ ë“¯ ì•ˆìœ¼ë¡œ í‘¹ êº¼ì ¸ ìˆìŒ (**Scooped out**).\n    - **âš ï¸ Trap (Box Shape):** ìœ„ì•„ë˜ê°€ ëª¨ë‘ í‰í‰í•œ ì‚¬ê°í˜• ëª¨ì–‘(Box-shaped) ë£¨í”„ëŠ” ì²œì‹ì´ ì•„ë‹ˆë¼ **Upper Airway Obstruction** (ì˜ˆ: Tracheal stenosis, Vocal cord dysfunction)ì…ë‹ˆë‹¤.\n2. **DLCO (Diffusing Capacity):** ì²œì‹ê³¼ COPDë¥¼ êµ¬ë¶„í•˜ëŠ” ê²°ì •ì  ë‹¨ì„œ(Tie-breaker).\n    - **Asthma:** DLCO **ì •ìƒ(Normal) í˜¹ì€ ì¦ê°€(Increased)**. (ì´ìœ : íí¬ ìì²´ëŠ” ë©€ì©¡í•˜ê±°ë‚˜ ê³µê¸°ê°€ ê°‡í˜€ì„œ ìš©ì ì´ ëŠ˜ì–´ë‚˜ë¯€ë¡œ).\n    - **Emphysema (COPD):** DLCO **ê°ì†Œ(Low)**. (ì´ìœ : íí¬ê°€ íŒŒê´´ë˜ì–´ ê°€ìŠ¤ êµí™˜ ë©´ì ì´ ì¤„ì–´ë“¦).\n---\n## 2. Acute Exacerbation (Status Asthmaticus) ğŸ”¥\nì‘ê¸‰ì‹¤ ì„¸íŒ…ì…ë‹ˆë‹¤. í™˜ìê°€ ìˆ¨ì„ í—ë–¡ì´ë©° ë“¤ì–´ì˜µë‹ˆë‹¤. **ê°€ì¥ ë§ì´ ì¶œì œë˜ëŠ” íŒŒíŠ¸**ì…ë‹ˆë‹¤.\n### ğŸš© Danger Signs (Red Flags)\n- **Wheezingì´ ì•ˆ ë“¤ë¦´ ë•Œ (Absent Wheezing):** ì¢‹ì€ ê²Œ ì•„ë‹™ë‹ˆë‹¤. ê¸°ë„ê°€ ë„ˆë¬´ ê½‰ ë§‰í˜€ì„œ ê³µê¸°ê°€ ì•„ì˜ˆ ì•ˆ í†µí•˜ëŠ” **\"Silent Chest\"** ìƒíƒœì…ë‹ˆë‹¤. í˜¸í¡ ë¶€ì „(Respiratory collapse) ì§ì „ì˜ ì´ˆì‘ê¸‰ ìƒí™©ì…ë‹ˆë‹¤.\n- **Normal PCO2 (e.g., 40-45 mmHg):**\n    - ì›ë˜ ì²œì‹ ë°œì‘ ì´ˆê¸°ì—ëŠ” ê³¼í˜¸í¡(Hyperventilation) ë•Œë¬¸ì— PCO2ê°€ ë‚®ì•„ì•¼(Respiratory Alkalosis) ì •ìƒì…ë‹ˆë‹¤.\n    - ë§Œì•½ PCO2ê°€ \"ì •ìƒ ë²”ìœ„\"ë¡œ ëŒì•„ì™”ë‹¤ë©´? í™˜ìê°€ ì§€ì³ì„œ(Fatigue) ë” ì´ìƒ ê³¼í˜¸í¡ì„ ëª»í•˜ê³  **CO2ê°€ ìŒ“ì´ê¸° ì‹œì‘í–ˆë‹¤**ëŠ” ëœ»ì…ë‹ˆë‹¤. **ì¦‰ì‹œ ì‚½ê´€(Intubation)**ì„ ì¤€ë¹„í•´ì•¼ í•©ë‹ˆë‹¤.\n### ğŸš‘ Emergency Treatment Algorithm\nìˆœì„œëŒ€ë¡œ ì™¸ìš°ì„¸ìš”. (O -> B -> S -> M -> I)\n1. **Oxygen:** SpO2 88-92% ëª©í‘œ (ì„ì‹ ë¶€ëŠ” >95%).\n2. **Bronchodilators (Dual):** SABA (Albuterol) + SAMA (Ipratropium). ì‘ê¸‰ì‹¤ì—ì„œëŠ” ì´ ë‘˜ì„ ì„ì€ **DuoNeb**ì´ Albuterol ë‹¨ë…ë³´ë‹¤ íš¨ê³¼ê°€ ì¢‹ìŠµë‹ˆë‹¤.\n3. **Systemic Steroids:** **Oral(ê²½êµ¬)ì´ë‚˜ IVë‚˜ íš¨ê³¼ëŠ” ê°™ìŠµë‹ˆë‹¤.** í•˜ì§€ë§Œ íš¨ê³¼ê°€ ë‚˜íƒ€ë‚˜ëŠ” ë° 4~6ì‹œê°„ì´ ê±¸ë¦¬ë¯€ë¡œ **ì˜¤ìë§ˆì ë°”ë¡œ(ASAP)** íˆ¬ì—¬í•´ì•¼ í•©ë‹ˆë‹¤ (Methylprednisolone IV or Prednisone PO).\n    - *ì£¼ì˜:* Inhaled Steroid(í¡ì…ì œ)ëŠ” ê¸‰ì„±ê¸°ì— ì“°ì§€ ì•ŠìŠµë‹ˆë‹¤.\n4. **Magnesium Sulfate (IV):** ì´ˆê¸° ì¹˜ë£Œì—ë„ ë°˜ì‘ì´ ì—†ì„ ë•Œ ì”ë‹ˆë‹¤. ê¸°ê´€ì§€ í‰í™œê·¼ì„ ì´ì™„ì‹œí‚µë‹ˆë‹¤.\n5. **Intubation:** ì˜ì‹ ì €í•˜, ì‚°ì¦ ì‹¬í™”(pH < 7.1), PCO2 ìƒìŠ¹ ì‹œ ìµœí›„ì˜ ìˆ˜ë‹¨.\n    - *ì°¸ê³ :* Epinephrineì€ Anaphylaxisê°€ ì•„ë‹Œ ì´ìƒ ì²œì‹ ë°œì‘ì— ë£¨í‹´ìœ¼ë¡œ ì“°ì§€ ì•ŠìŠµë‹ˆë‹¤.\n---\n## 3. Chronic Management & Special Cases\ní‡´ì› í›„ ì™¸ë˜ ê´€ë¦¬ ì „ëµì…ë‹ˆë‹¤.\n### ğŸ’Š Treatment Steps (Step-up Therapy)\n- **ì ˆëŒ€ ê¸ˆê¸°:** LABA (Long-acting beta agonist)ë¥¼ **ë‹¨ë…(Monotherapy)**ìœ¼ë¡œ ì“°ë©´ ì‚¬ë§ë¥ ì´ ì¦ê°€í•©ë‹ˆë‹¤. ë¬´ì¡°ê±´ ICSì™€ ì„ì–´ ì¨ì•¼ í•©ë‹ˆë‹¤. ì—¼ì¦ì´ ë¬¸ì œì¸ê±°ì§€, ë¬´ì‘ì • ë„“íˆê³ , ì—¼ì¦ì€ ë¬´ì‹œí•˜ë©´ì•ˆëœë‹¤!\n- **Step 1 (Mild Intermittent):** ì¦ìƒ ìˆì„ ë•Œë§Œ **SABA** (Albuterol) í˜¹ì€ Low-dose ICS-Formoterol (PRN).\n- **Step 2 (Mild Persistent):** **Daily Low-dose ICS** (Inhaled Corticosteroid) ì¶”ê°€.\n- **Step 3:** Low-dose ICS + **LABA** ì¶”ê°€.\n- **Step 5 (Refractory):** **Biologics** ê³ ë ¤.\n    - High IgE (Allergic): **Omalizumab** (Anti-IgE).\n    - High Eosinophils: **Mepolizumab, Reslizumab** (Anti-IL5).\n- *Side Effect:* ICS ì‚¬ìš© í›„ êµ¬ê°• ìº”ë””ë‹¤ì¦(Oral Thrush) ì˜ˆë°©ì„ ìœ„í•´ ì…ì„ í—¹êµ¬ê²Œ(Gargle/Rinse) êµìœ¡í•©ë‹ˆë‹¤.\n### ğŸ¤° Pregnancy & Asthma\n- **Rule:** **\"ì—„ë§ˆê°€ ìˆ¨ ëª» ì‰¬ë©´ ì•„ê¸°ë„ ìˆ¨ ëª» ì‰°ë‹¤.\"** ì¹˜ë£Œ ì•ˆ í•˜ëŠ” ê²ƒì´ ì•½ë¬¼ ë¶€ì‘ìš©ë³´ë‹¤ í›¨ì”¬ ìœ„í—˜í•©ë‹ˆë‹¤.\n- Target SpO2: **> 95%** (ì¼ë°˜ì¸ë³´ë‹¤ ë†’ê²Œ ì¡ìŒ).\n- ì•ˆì „í•œ ì•½ë¬¼: Albuterol(SABA), Budesonide(ICS) ëª¨ë‘ ì•ˆì „í•©ë‹ˆë‹¤. ì ê·¹ì ìœ¼ë¡œ ì¹˜ë£Œí•˜ì„¸ìš”.\n- **ì£¼ì˜:** ë¶„ë§Œ ì¤‘ ìê¶ ìˆ˜ì¶•ì„ ì–µì œí•  ìˆ˜ ìˆìœ¼ë¯€ë¡œ Epinephrineì€ í”¼í•©ë‹ˆë‹¤ (ë‹¨, ì•„ë‚˜í•„ë½ì‹œìŠ¤ ì œì™¸).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-353","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"### ğŸƒ Exercise-Induced Bronchoconstriction (EIB)\n- ì¦ìƒ: ìš´ë™ ì‹œì‘ 5~10ë¶„ í›„ ê¸°ì¹¨/ìŒ•ìŒ•ê±°ë¦¼, íœ´ì‹ ì‹œ í˜¸ì „ë¨.\n- ê¸°ì „: ì°¨ê°‘ê³  ê±´ì¡°í•œ ê³µê¸°ê°€ ê¸°ë„ë¡œ ë“¤ì–´ì˜¤ë©° ë°œìƒ.\n- ì¹˜ë£Œ: ìš´ë™ **10~20ë¶„ ì „**ì— SABA (Albuterol) ì‚¬ìš©. (ë§¤ì¼ ìš´ë™í•˜ëŠ” ì„ ìˆ˜ë¼ë©´ Daily ICS+LABA ê³ ë ¤).\n---\n## 4. The \"Look-alikes\" (Differential Diagnosis)\nì²œì‹ì¸ ì¤„ ì•Œì•˜ëŠ”ë° ì•½ì´ ì•ˆ ë“£ë‚˜ìš”? ì´ê±¸ ì˜ì‹¬í•˜ì„¸ìš”.\n### A. Bronchiectasis (ê¸°ê´€ì§€í™•ì¥ì¦)\n- **íŠ¹ì§•:** ê¸°ë„ê°€ ì˜êµ¬ì ìœ¼ë¡œ ëŠ˜ì–´ë‚˜ê³  íŒŒê´´ë¨. ì„¬ëª¨(Cilia)ê°€ ë§ê°€ì ¸ ê°€ë˜ ë°°ì¶œ ëª» í•¨.\n- **Keyword:** **\"Cupfuls of sputum\"** (ê°€ë˜ê°€ ì»µì„ ì±„ìš¸ ì •ë„ë¡œ ë§ì´ ë‚˜ì˜´), ëƒ„ìƒˆê°€ ì§€ë…í•¨(Foul-smelling).\n- **CT ì†Œê²¬:**\n    - **Signet Ring Sign:** ê¸°ë„ê°€ í˜ˆê´€ë³´ë‹¤ ì»¤ì ¸ì„œ ë°˜ì§€ ëª¨ì–‘ì²˜ëŸ¼ ë³´ì„.\n    - **Tram-tracking:** ê¸°ì°¨ ì„ ë¡œì²˜ëŸ¼ í‰í–‰í•˜ê²Œ ëŠ˜ì–´ë‚œ ê¸°ë„.\n- **ì¹˜ë£Œ:** Pulmonary Hygiene (ê°€ë˜ ë°°ì¶œ ë¬¼ë¦¬ì¹˜ë£Œ), ê°ì—¼ ì‹œ í•­ìƒì œ.\n### B. ABPA (Allergic Bronchopulmonary Aspergillosis)\n- **í™˜ìêµ°:** ê¸°ì¡´ì— **Asthma**ë‚˜ **Cystic Fibrosis(ë‚­ì„±ì„¬ìœ ì¦)**ê°€ ìˆëŠ” í™˜ì.\n- **ë³‘íƒœìƒë¦¬:** íì— ìˆëŠ” *Aspergillus*(ê³°íŒ¡ì´)ì— ëŒ€í•´ ê³¼ë„í•œ **ì•Œë ˆë¥´ê¸° ë°˜ì‘**ì„ ë³´ì„ (ê°ì—¼ ì•„ë‹˜!).\n- **Triad (ì§„ë‹¨ ë‹¨ì„œ):**\n    1. Asthma history.\n    2. **Brown Mucus Plugs** (ê°ˆìƒ‰ ê°€ë˜ ë©ì–´ë¦¬).\n    3. **Sky-high IgE** (>1000) & Eosinophilia.\n- **ì¹˜ë£Œ:** Systemic Steroids (ì•Œë ˆë¥´ê¸° ì–µì œ) + Itraconazole (ê³°íŒ¡ì´ ì–µì œ - Antigen burden ì¤„ì´ê¸°).\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-373","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"recap_summary","text":"## ğŸ¯ Recap (ì‹œí—˜ ì§ì „ ìš”ì•½)\níŒŸìºìŠ¤íŠ¸ ë§ˆì§€ë§‰ 1ë¶„ ìš”ì•½ì…ë‹ˆë‹¤. ì´ ë‚´ìš©ì€ ìë‹¤ê°€ë„ íŠ€ì–´ë‚˜ì™€ì•¼ í•©ë‹ˆë‹¤.\n1. **Diagnosis:** Spirometry FEV1/FVC **< 0.7**. Albuterol ë°˜ì‘ì„± ìˆìŒ (**>12% AND 200ml**).\n2. **Rule Out:** PFT ì •ìƒì¸ë° ì˜ì‹¬ë˜ë©´ **Methacholine Challenge**. (Negative result = No Asthma).\n3. **Status Asthmaticus Rx:** **Oxygen â†’ DuoNeb (SABA/SAMA) â†’ Systemic Steroids (Early!) â†’ Magnesium**.\n4. **Scary Sign:** ì²œì‹ ë°œì‘ ì¤‘ **\"Normal PCO2\"**ëŠ” í˜¸í¡ ê·¼ìœ¡ì´ ì§€ì³¤ë‹¤ëŠ” ëœ». **Intubation** ì¤€ë¹„!.\n5. **Pregnancy:** SpO2 **>95%** ìœ ì§€. PCO2ê°€ ì •ìƒì´ë©´ íƒœì•„ì—ê²ŒëŠ” ì‚°ì†Œ ë¶€ì¡±ì¼ ìˆ˜ ìˆìŒ (ì„ì‚°ë¶€ëŠ” ì›ë˜ ê³¼í˜¸í¡ ìƒíƒœì„).\n6. Bronchiectasis: HRCT: signet ring sign, tramtrack, prulent sputum â†‘ , foul smelling\n7. **ABPA:** ì²œì‹,CF í™˜ì + **ê°ˆìƒ‰ ê°€ë˜(Brown mucus)** + **ë†’ì€ IgE** + í ì¹¨ìœ¤(Infiltrates). ì¹˜ë£ŒëŠ” **Steroid + Itraconazole**.\n8. **Asthma Medication Rule:** **LABA ë‹¨ë… ì‚¬ìš© ê¸ˆì§€** (ì‚¬ë§ë¥  ì¦ê°€). í•­ìƒ ICSì™€ í•¨ê»˜.\n---\n---\n# ğŸ« USMLE Deep Dive: Restrictive Lung Diseases\n**Topic:** Interstitial Lung Disease (ILD), Hypersensitivity Pneumonitis, Sarcoidosis, Pulmonary Hypertension, OSA, Breath-holding spells\n## ğŸŒ³ The Big Picture: Diagnosis Tree\nì œí•œì„± íì§ˆí™˜ì€ \"íê°€ ë”±ë”±í•´ì„œ ê³µê¸°ê°€ ëª» ë“¤ì–´ê°€ëŠ” ë³‘\"ì…ë‹ˆë‹¤. ì§„ë‹¨ì˜ ê°ˆë¦¼ê¸¸(Fork in the road)ì€ **DLCO(Diffusing Capacity)**ì…ë‹ˆë‹¤.\nPlaintext","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-383","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","recap","diagnosis","tree"]}
{"chunk_type":"transcript_chunk","text":"`Restrictive Lung Disease (TLC < 80%, FEV1/FVC Normal or High)\nâ”‚\nâ”œâ”€â”€ Low DLCO (í ìì²´ì˜ ë¬¸ì œ: Interstitial Lung Disease)\nâ”‚   â”œâ”€â”€ Hypersensitivity Pneumonitis (Acute vs Chronic)\nâ”‚   â”œâ”€â”€ Sarcoidosis (Young African American female, Hilar Adenopathy)\nâ”‚   â”œâ”€â”€ Pneumoconiosis (Silicosis, Asbestosis etc.)\nâ”‚   â”œâ”€â”€ Drug/Radiation Induced (Bleomycin, Amiodarone, Methotrexate)\nâ”‚   â””â”€â”€ Idiopathic Pulmonary Fibrosis (IPF: Diagnosis of Exclusion)\nâ”‚\nâ””â”€â”€ Normal DLCO (í ë°–ì˜ ë¬¸ì œ: Extrinsic Restriction)\n    â”œâ”€â”€ Chest Wall (Obesity, Kyphoscoliosis)\n    â””â”€â”€ Neuromuscular (ALS, Myasthenia Gravis, Guillain-Barre)`\n---\n## 1. Diagnostic Framework: The Mechanics\nì œí•œì„± íì§ˆí™˜(Restrictive Lung Disease)ì˜ í•µì‹¬ ê°œë…ì„ ë¨¼ì € ì¡ê³  ê°‘ì‹œë‹¤.\n- **Pathophysiology:** íê°€ ë”±ë”±í•œ ê°€ì£½ ì£¼ë¨¸ë‹ˆ(Stiff leather bag)ì²˜ëŸ¼ ë³€í–ˆìŠµë‹ˆë‹¤. íŒ½ì°½ì´ ì•ˆ ë˜ë‹ˆ ê³µê¸° ìš©ì (Volume)ì´ ì¤„ì–´ë“­ë‹ˆë‹¤.\n- **PFT Findings (Must Know):**\n    - **TLC (Total Lung Capacity):** **ê°ì†Œ (Low)**. ì´ê²Œ ì •ì˜ì…ë‹ˆë‹¤.\n    - **FEV1/FVC Ratio:** **ì •ìƒ í˜¹ì€ ì¦ê°€ (Normal or Increased > 0.8)**.\n        - ì´ìœ : ê³µê¸° ì–‘ ìì²´ëŠ” ì ì§€ë§Œ, ê¸°ë„ëŠ” ë»¥ ëš«ë ¤ ìˆì–´ì„œ ë‚´ë±‰ëŠ” ì†ë„(Recoil)ëŠ” ì—„ì²­ ë¹ ë¦…ë‹ˆë‹¤ (ë§ˆì¹˜ íŒ½íŒ½í•œ ê³ ë¬´ì¤„ì²˜ëŸ¼).\n- **The \"Fork in the Road\" - DLCO:**\n    - **Low DLCO:** í ì¡°ì§(Interstitium)ì´ë‚˜ í˜ˆê´€ì´ ë§ê°€ì ¸ì„œ ê°€ìŠ¤ êµí™˜ì´ ì•ˆ ë¨. â†’ **ILD, Pulmonary HTN**.\n    - **Normal DLCO:** íëŠ” ë©€ì©¡í•œë° ë°–ì—ì„œ ëª» ëŠ˜ì–´ë‚˜ê²Œ ëˆ„ë¦„. â†’ **ë¹„ë§Œ, ì²™ì¶”ì¸¡ë§Œì¦, ì‹ ê²½ê·¼ìœ¡ì§ˆí™˜**.\n---\n## 2. Hypersensitivity Pneumonitis (ê³¼ë¯¼ì„± íë ´)\n**\"Bird Fancier's Lung\"** ë˜ëŠ” **\"Farmer's Lung\"**. ì™¸ë¶€ í•­ì›(ìƒˆ, ê³°íŒ¡ì´ ë“±)ì— ëŒ€í•œ ì•Œë ˆë¥´ê¸° ë°˜ì‘ì…ë‹ˆë‹¤.\n### A. Acute Form (ê¸‰ì„±)\n- **Scenario:** ë¹„ë‘˜ê¸°ì¥ ì²­ì†Œ í›„ 4~6ì‹œê°„ ë’¤ ê°‘ìê¸° ì—´ë‚˜ê³  ê¸°ì¹¨í•¨ (Flu-like symptoms).\n- **Key Feature:** **ì›”ìš”ì¼ ì•„ì¹¨ ì¶œê·¼í•˜ë©´ ì•„í”„ê³ , ì£¼ë§ì— ì‰¬ë©´ ì¢‹ì•„ì§.** (í•­ì› ë…¸ì¶œ ì‹œì—ë§Œ ì¦ìƒ ë°œìƒ).\n- **Treatment:** **íšŒí”¼(Avoidance)**. ì›ì¸ë§Œ í”¼í•˜ë©´ 100% ì¢‹ì•„ì§ (Reversible).\n### B. Chronic Form (ë§Œì„±)\n- **Scenario:** ë‚®ì€ ë†ë„ë¡œ ì§€ì† ë…¸ì¶œ (ì§‘ì•ˆì— ê³°íŒ¡ì´ ë“±). ì„œì„œíˆ ìˆ¨ì´ ì°¨ê³  ë§ˆë¥¸ ê¸°ì¹¨. ì—´(Fever)ì€ ì—†ìŒ.\n- **Diagnosis:**\n    - **BAL (Bronchoalveolar Lavage):** **High Lymphocytes** (ë¦¼í”„êµ¬ ì¦ê°€).\n        - *ë¹„êµ:* IPFë‚˜ ë‹¤ë¥¸ ì§ˆí™˜ì€ ì£¼ë¡œ Neutrophilì´ ì¦ê°€í•¨.\n- **CT Finding:** **Upper lobe fibrosis**.\n- **Treatment:** ì›ì¸ íšŒí”¼ + ìŠ¤í…Œë¡œì´ë“œ. (ì´ë¯¸ ì„¬ìœ í™”ê°€ ì§„í–‰ë˜ë©´ ë¹„ê°€ì—­ì ì¼ ìˆ˜ ìˆìŒ).\n---\n## 3. Sarcoidosis (ìœ ìœ¡ì¢…ì¦)\n**\"The Systemic Granuloma Machine\"**. ì „ì‹  ì§ˆí™˜ì´ì§€ë§Œ íë¥¼ ê°€ì¥ ì¢‹ì•„í•©ë‹ˆë‹¤.\n- **Patient Profile:** 20~40ëŒ€ **African American Female**.\n- **Classic Presentation:** ìš°ì—°íˆ ì°ì€ X-rayì—ì„œ ë°œê²¬ëœ **Bilateral Hilar Lymphadenopathy (BHL)**. ì¦ìƒì€ ì—†ì„ ìˆ˜ë„ ìˆê³ , ë§ˆë¥¸ ê¸°ì¹¨ì´ë‚˜ í˜¸í¡ê³¤ë€ì´ ìˆì„ ìˆ˜ ìˆìŒ.\n- **Systemic Symptoms:**\n    - **Skin:** **Erythema Nodosum** (ì •ê°•ì´ì˜ ì•„í”ˆ ë¶‰ì€ ê²°ì ˆ), Lupus Pernio (ì½”/ëº¨ì˜ ë³´ë¼ìƒ‰ ë°œì§„ - íŠ¹ì´ë„ ë†’ìŒ).\n    - **â˜… Eyes:** **Uveitis** (Red eye, Pain, Photophobia). ëª¨ë“  Sarcoidosis í™˜ìëŠ” ì•ˆê³¼ ê²€ì§„ í•„ìˆ˜!\n    - **â˜… Heart:** AV Block (Syncope, Sudden death ìœ„í—˜).\n    - **Neuro:** Bell's Palsy (CN 7 palsy).\n- **Labs (The Calcium Connection):**\n    - **Hypercalcemia:** ìœ¡ì•„ì¢…(Granuloma) ë‚´ì˜ Macrophageê°€ ì œë©‹ëŒ€ë¡œ **Vitamin Dë¥¼ í™œì„±í™”**ì‹œì¼œ ì¹¼ìŠ˜ í¡ìˆ˜ë¥¼ ëŠ˜ë¦¼. (PTHëŠ” ë‚®ìŒ).\n    - **High ACE Level:** ìœ¡ì•„ì¢…ì—ì„œ ë¶„ë¹„. (ì§„ë‹¨ì  ê°€ì¹˜ëŠ” ë‚®ìŒ, ê²½ê³¼ ê´€ì°°ìš©).\n- **Treatment:**\n    - **â˜… No Symptoms:** **ì¹˜ë£Œ ì•ˆ í•¨ (Observation)**. ëŒ€ë¶€ë¶„ 2ë…„ ë‚´ ì €ì ˆë¡œ ì¢‹ì•„ì§.\n    - **Symptoms/Organ Damage:** **Systemic Steroids**.\n---\n## 4. Pulmonary Hypertension (íë™ë§¥ ê³ í˜ˆì••)\níí˜ˆê´€ì˜ ì••ë ¥ì´ ë†’ì•„ì ¸ ìš°ì‹¬ë¶€ì „(Right Heart Failure)ìœ¼ë¡œ ì´ì–´ì§€ëŠ” ë³‘ì…ë‹ˆë‹¤.\n- **Classification (WHO Groups):**\n    - **Group 1 (PAH):** íë™ë§¥ ìì²´ ë¬¸ì œ. (Idiopathic, Connective Tissue Disease, HIV, Drugs).\n    - **Group 2:** **Left Heart Disease** (ê°€ì¥ í”í•¨). ì¢Œì‹¬ë¶€ì „ìœ¼ë¡œ í”¼ê°€ íë¡œ ì—­ë¥˜.\n    - **Group 3:** **Lung Disease** (Hypoxia). COPD, ILD ë“±ìœ¼ë¡œ ì¸í•œ í˜ˆê´€ ìˆ˜ì¶•. (hypoxic vasoconstriction)\n    - **Group 4:** **Chronic Thromboembolic (CTEPH)**. ë§Œì„± íìƒ‰ì „ì¦.\n- **Diagnosis:**\n    - ìš´ë™í•˜ë‹¤ê°€ ì‚¬ê³ , loud P2, backup sign (JVD..)\n    - **Screening:** **Echocardiogram (ì‹¬ì´ˆìŒíŒŒ)**. RV pressure ì¶”ì •.\n    - **Confirmation (Gold Standard):** **Right Heart Catheterization (RHC)**. ì§ì ‘ ì••ë ¥ì„ ìŸ€ì„ ë•Œ **mPAP â‰¥ 20 mmHg**.\n- **Treatment:**\n    - Group 2, 3: ì›ì¸ ì§ˆí™˜(ì‹¬ë¶€ì „, COPD) ì¹˜ë£Œ. í˜ˆê´€í™•ì¥ì œ í•¨ë¶€ë¡œ ì“°ë©´ ì•ˆ ë¨ (V/Q mismatch ì•…í™” ìœ„í—˜).\n    - Group 1 (PAH): **Pulmonary Vasodilators** (Sildenafil, Bosentan, Epoprostenol).\n    - Group 4 (CTEPH): ìˆ˜ìˆ  ê°€ëŠ¥í•˜ë©´ **Thrombectomy** (ì™„ì¹˜ ê°€ëŠ¥).","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-393","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"---\n## 5. Sleep & Pediatrics (Low Yield but Tricky)\n### ğŸ˜´ Obstructive Sleep Apnea (OSA)\n- **Risk Factors:** Obesity, Thick neck (>17 inches men, >16 inches women).\n- **Screening:** **STOP-BANG** questionnaire.\n- **Diagnosis:** **Polysomnography (Sleep Study)**. AHI (Apnea-Hypopnea Index) > 5.\n- **Treatment:** Weight loss + **CPAP** (Gold Standard).\n### ğŸ‘¶ Breath-Holding Spells (Pediatrics)\n- **Scenario:** 6ê°œì›”~6ì„¸ ì•„ì´ê°€ ìš¸ê±°ë‚˜ í™”ë‚˜ì„œ ìˆ¨ì„ ì°¸ë‹¤ê°€ íŒŒë—ê²Œ ì§ˆë¦¬ê³ (Cyanotic) ê¸°ì ˆí•¨(Pass out).\n- **Management:** **Reassurance**. ì •ìƒ ë°œë‹¬ ê³¼ì •ì„. ê·¸ëƒ¥ ë‘ë©´ ê¹¨ì–´ë‚¨.\n- **Workup:** ë¹ˆí˜ˆ(Iron deficiency anemia)ì´ ìˆìœ¼ë©´ ë” ìì£¼ ë°œìƒí•˜ë¯€ë¡œ **CBC/Ferritin** ì²´í¬í•´ ë³¼ ìˆ˜ ìˆìŒ.\n---\n## ğŸ¯ Recap (High Yield Summary)\nì´ê²ƒë§Œì€ ê¼­ ê¸°ì–µí•˜ì„¸ìš”.\n1. **Restrictive Lung Disease:** **Low TLC**, **Normal/High FEV1/FVC**.\n2. **DLCO is King:**\n    - Low DLCO = **Interstitial Lung Disease (ILD)** (Lung tissue problem).\n    - Normal DLCO = **Chest Wall/Neuromuscular** (Pump problem).\n3. **Hypersensitivity Pneumonitis:**\n    - Acute: **Flu-like**, Avoidance = Cure.\n    - Chronic: Upper lobe fibrosis, **Lymphocytosis on BAL**.\n4. **Sarcoidosis:** **Black female**, **Hilar Adenopathy**, **Hypercalcemia** (High Vit D), Non caseating granuloma, AV block, **Uveitis**. ë¬´ì¦ìƒì´ë©´ ì¹˜ë£Œ X â˜…\n5. **Pulmonary HTN:** screening: Echo â†’ í™•ì§„ì€ **Right Heart Cath**. Group 2(Left heart)ê°€ ì œì¼ í”í•¨. loud P2. know the group.\n6. OSA - ì•„ì´ì˜ ê²½ìš° ì†Œë³€ë¬¸ì œ, ì•„ì´ëŠ” ìˆ˜ìˆ !\n7. **Idiopathic Pulmonary Fibrosis (IPF):**\n    - **Honeycombing** (CT), **Velcro crackles** (Exam).\n    - ì¹˜ë£ŒëŠ” **Antifibrotics** (Pirfenidone, Nintedanib) - ì§„í–‰ë§Œ ëŠ¦ì¶¤.\n---","subject":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","page_title":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","episode":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","section_path":["LM_pulmo 2f246f2986ee8075b36bd165586e44fc"],"source_doc_id":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","source_page":null,"source_anchor":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc-413","focus_area":"LM_pulmo 2f246f2986ee8075b36bd165586e44fc","tags":["usmle-step2","core","diagnosis","treatment"]}
{"chunk_type":"transcript_chunk","text":"# LM_ pulmo 2\n# ğŸ« Pulmonary Embolism (PE) : The USMLE Framework\n### âš¡ One Line Vibe\n**\"Unstable patient gets Heparin first; Stable patient gets the Scan first.\"** (ì‚´ ë†ˆì€ ê²€ì‚¬í•˜ê³ , ì£½ì„ ë†ˆì€ ì¼ë‹¨ ì•½ë¶€í„° ì³ë¼.)\n### ğŸ“ Summary\nì´ ê°•ì˜ëŠ” USMLE Step 2 CKë¥¼ ìœ„í•´ Pulmonary Embolism(PE)ì˜ ì§„ë‹¨ ì•Œê³ ë¦¬ì¦˜(Wells Criteria), ìƒë¦¬í•™ì  ì‚¬ë§ ê¸°ì „(Obstructive Shock), ê·¸ë¦¬ê³  í™˜ìì˜ Stabilityì— ë”°ë¥¸ ì¹˜ë£Œ ì „ëµ(Anticoagulation vs Thrombolysis)ì„ ë‹¤ë£¹ë‹ˆë‹¤. ë˜í•œ ì‹œí—˜ì— ìì£¼ ë‚˜ì˜¤ëŠ” íŠ¹ìˆ˜ ìƒí™©(Fat/Air Embolism, Pregnancy)ì— ëŒ€í•œ \"High Yield\" í¬ì¸íŠ¸ë“¤ì„ ì§šì–´ì¤ë‹ˆë‹¤.\n---\n### ğŸŒ³ Top-down Classification (Mental Model)\nPEë¼ëŠ” ê±°ëŒ€í•œ ìˆ²ì„ ë³¼ ë•Œ, í™˜ìê°€ **\"ì£½ì–´ê°€ëŠëƒ(Massive)\" ì•„ë‹ˆë©´ \"ë²„í‹°ê³  ìˆëŠëƒ(Stable/Submassive)\"**ê°€ ê°€ì¥ ì¤‘ìš”í•œ ê°ˆë¦¼ê¸¸ì…ë‹ˆë‹¤.\n`PULMONARY_EMBOLISM_WORKFLOW\n â”œâ”€â”€ 1. Initial_Approach (The Fork in the Road)\n â”‚    â”œâ”€â”€ Hemodynamically_Unstable (BP < 90/50)\n â”‚    â”‚    â””â”€â”€ â˜… ACTION: Empiric Anticoagulation (Start Heparin NOW) -> Bedside Echo\n â”‚    â””â”€â”€ Hemodynamically_Stable\n â”‚         â””â”€â”€ â˜… ACTION: Risk Stratification (Wells Score)\n â”‚\n â”œâ”€â”€ 2. Diagnostic_Algorithm (Wells Score Cutoff = 4)\n â”‚    â”œâ”€â”€ PE_Likely (Score > 4)\n â”‚    â”‚    â””â”€â”€ GO_TO: CT Pulmonary Angio (CTPA)\n â”‚    â””â”€â”€ PE_Unlikely (Score <= 4)\n â”‚         â””â”€â”€ GO_TO: D-Dimer (High Negative Predictive Value)\n â”‚              â”œâ”€â”€ Negative -> Go Home (PE Excluded)\n â”‚              â””â”€â”€ Positive -> CTPA\n â”‚\n â”œâ”€â”€ 3. Pathophysiology (Why they die)\n â”‚    â””â”€â”€ RV_Afterload_Spike -> RV_Dilation -> Septal_Bowing -> LV_Compression -> Obstructive_Shock\n â”‚\n â”œâ”€â”€ 4. Treatment_Hierarchy\n â”‚    â”œâ”€â”€ Standard (Stable) -> Anticoagulation (Heparin, LMWH, DOACs)\n â”‚    â”œâ”€â”€ Massive (Shock) -> Thrombolysis (tPA) or Embolectomy\n â”‚    â””â”€â”€ Contraindication to AC -> IVC Filter\n â”‚\n â””â”€â”€ 5. The_Cousins (Non-Thrombotic)\n      â”œâ”€â”€ Fat_Embolism (Long bone fx + Petechial Rash)\n      â””â”€â”€ Air_Embolism (Central line/Surgery + Position maneuver)`\n---\n## 2. Diagnosis: Wells Criteria (The Gatekeeper)\në¬´í„±ëŒ€ê³  CTë¶€í„° ì°ì§€ ë§ê³ , **Pre-test Probability**ë¥¼ ë¨¼ì € ê³„ì‚°í•´ì•¼ í•¨.\n***ì…ì›ì¤‘ì¸ í™˜ìê°€ ìˆ¨ì°¨ê³ , pleuritic chest pain, mild fever.. now what..?***\n### ğŸ”¢ Modified Wells Criteria ì ìˆ˜ ê³„ì‚°ë²•\n- **+3.0ì  (ê°€ì¥ í¼):**\n    1. **Clinical signs of DVT:** ë‹¤ë¦¬ê°€ ë¶€ì—ˆê±°ë‚˜(Swollen leg), ì¢…ì•„ë¦¬ í†µì¦(Tenderness).\n    2. **Alternative diagnosis less likely than PE:** \"ì´ê±° ë§ê³ ëŠ” ì„¤ëª…ì´ ì•ˆ ë¨\" (ì„ìƒì˜ì˜ ì£¼ê´€ì  íŒë‹¨ì´ ì¤‘ìš”). íë ´ì•„ë‹ˆë‹¤â€¦\n- **+1.5ì :**\n    1. **Previous History:** ê³¼ê±° PE ë˜ëŠ” DVT ë³‘ë ¥.\n    2. **Tachycardia:** ì‹¬ë°•ìˆ˜ > 100íšŒ. â˜…\n    3. **Recent Surgery or Immobilization:**\n        - ìµœê·¼ 4ì£¼ ì´ë‚´ ì£¼ìš” ìˆ˜ìˆ .\n        - 3ì¼ ì´ìƒì˜ ì¹¨ìƒ ì•ˆì •(Bed rest).\n- **+1.0ì :**\n    1. **Hemoptysis:** ê°í˜ˆ (ê¸°ì¹¨í•  ë•Œ í”¼ ë‚˜ì˜´ -> ì•”ì´ë‚˜ íê²½ìƒ‰ ì‹œì‚¬).\n    2. **Active Cancer:** í˜„ì¬ ì¹˜ë£Œ ì¤‘ì´ê±°ë‚˜ 6ê°œì›” ë‚´ ì¹˜ë£Œë°›ì€ ì•”.\n---\n## 3. The Diagnostic Algorithm (Action Plan)\n### A. ì ìˆ˜ í•´ì„ (The Split)\n- **Score â‰¤ 4 (PE Unlikely):**\n    - **Action:** **D-Dimer** ê²€ì‚¬.\n    - **ì´ìœ :** D-DimerëŠ” **Negative Predictive Value(ìŒì„± ì˜ˆì¸¡ë„)**ê°€ ë§¤ìš° ë†’ìŒ. ì¦‰, ìˆ˜ì¹˜ê°€ ì •ìƒì´ë©´(<500) PEëŠ” ì ˆëŒ€ ì•„ë‹ˆë¼ê³  ë³´ê³  **Workup ì¢…ë£Œ(ì§‘ì— ë³´ëƒ„)** ê°€ëŠ¥.\n    - **ì£¼ì˜:** ì–‘ì„± ë‚˜ì˜¤ë©´ ë¹„íŠ¹ì´ì ì´ë¯€ë¡œ CT ì°ì–´ì•¼ í•¨.\n- **Score > 4 (PE Likely):**\n    - Anticoagualtion â†’ CTPA\n    - **Action:** **CT Pulmonary Angiography (CTPA)** ì§í–‰.\n    - **í•µì‹¬:** D-dimer ê±´ë„ˆëœ€ (ì‹œê°„ ë‚­ë¹„).","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-1","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","mnemonic","tree"]}
{"chunk_type":"transcript_chunk","text":"### B. The \"Safety First\" Rule (ë§¤ìš° ì¤‘ìš” â˜…)\n- ë§Œì•½ í™˜ìê°€ **Likely Score (>4)**ì´ê³  **Distress(í˜¸í¡ê³¤ë€ ë“±)**ê°€ ì‹¬í•˜ë‹¤ë©´?\n- **CT ì°ìœ¼ëŸ¬ ê°€ê¸° ì „ì— í•­ì‘ê³ ì œ(Heparin)ë¶€í„° íˆ¬ì—¬.**\n- *Logic:* CTì‹¤ë¡œ ì´ë™í•˜ëŠ” ë„ì¤‘ ì‚¬ë§í•  í™•ë¥ ì´ í—¤íŒŒë¦° í•œ ë²ˆ ë§ê³  ì¶œí˜ˆ ìƒê¸¸ í™•ë¥ ë³´ë‹¤ ë†’ìŒ.\n- *ì˜ˆì™¸:* ë‡Œì¶œí˜ˆ, í™œì„± ì¶œí˜ˆ(GI bleed) ë“± ê¸ˆê¸°ì¦ì´ ìˆì„ ë•Œë§Œ ì œì™¸.\n### C. Imaging Modalities (ì˜ìƒ ê²€ì‚¬)\n1. **CT Pulmonary Angiography (CTPA):** Gold Standard. í™•ì§„ ê²€ì‚¬.\n2. **V/Q Scan (Ventilation/Perfusion):**\n    - **ì‚¬ìš© ëŒ€ìƒ:** ì‹ ë¶€ì „(Renal failure), ì¡°ì˜ì œ ì•Œë ˆë¥´ê¸°(Contrast allergy), **ì„ì‚°ë¶€(Pregnancy)**.\n    - *Note:* ì„ì‚°ë¶€ëŠ” íƒœì•„ ë°©ì‚¬ì„  í”¼í­ ë¬¸ì œì™€ ì¡°ì˜ì œ ì´ìŠˆ ë•Œë¬¸ì— V/Qê°€ ì„ í˜¸ë˜ê¸°ë„ í•¨.\n---\n## 4. Signs & Symptoms\n### ğŸ©» Chest X-ray Signs (ì˜¤ë””ì˜¤ì—ì„œ ì–¸ê¸‰ëœ 3ëŒ€ì¥)\nì—‘ìŠ¤ë ˆì´ëŠ” ë³´í†µ ì •ìƒì´ì§€ë§Œ, ë‹¤ìŒ ì†Œê²¬ì´ ë³´ì´ë©´ PEë¥¼ ê°•ë ¥ ì‹œì‚¬.\n1. **Hampton's Hump:**\n    - íì˜ ê°€ì¥ìë¦¬(Periphery)ì— ë³´ì´ëŠ” **ìê¸° ëª¨ì–‘(Wedge-shaped)ì˜ ìŒì˜**.\n    - ì˜ë¯¸: íê²½ìƒ‰(Lung infarction)ì´ ì¼ì–´ë‚œ ë¶€ìœ„.\n2. **Westermark Sign:**\n    - í˜ˆê´€ì´ ê°‘ìê¸° ëš ëŠê²¨ ë³´ì„(Sharp cutoff). ê·¸ ë’¤ìª½ íì•¼ê°€ ì–´ë‘¡ê²Œ ë³´ì„(Oligemia).\n    - ì˜ë¯¸: í˜ˆì „ ë•Œë¬¸ì— í”¼ê°€ ì•ˆ ê°€ì„œ í˜ˆê´€ ìŒì˜ì´ ì‚¬ë¼ì§„ ê²ƒ.\n3. **Fleischner Sign:**\n    - ì¤‘ì‹¬ íë™ë§¥(Central Pulmonary Artery)ì´ ë¹µë¹µí•˜ê²Œ ëŠ˜ì–´ë‚¨(Dilated).\n    - ì˜ë¯¸: ë§‰íŒ ê³³ ë’¤ìª½ìœ¼ë¡œ ì••ë ¥ì´ ì°¨ì„œ í˜ˆê´€ì´ ë¶ˆë£©í•´ì§(Bulging).\n### âš¡ ECG (ì‹¬ì „ë„)\n- **Sinus Tachycardia:** ê°€ì¥ í”í•œ ì†Œê²¬ (Most common).\n- **S1Q3T3:**\n    - Lead Iì—ì„œ SíŒŒ ê¹Šì–´ì§, Lead IIIì—ì„œ QíŒŒì™€ TíŒŒ ì—­ìœ„(Inversion).\n    - *Real Talk:* ì¡±ë³´ì—ëŠ” ë‚˜ì˜¤ì§€ë§Œ ì‹¤ì œë¡œëŠ” ë“œë¬¾(Rare).\n- **T-wave Inversions (V1-V4):**\n    - *Right Heart Strain(ìš°ì‹¬ì‹¤ ë¶€í•˜)**ì„ ë³´ì—¬ì£¼ëŠ” ë” ì˜ˆë¯¼í•œ ì§€í‘œ.\n### ğŸŒ¡ ê¸°íƒ€ ì¦ìƒ\n- **Syncope (ì‹¤ì‹ ):** ë§¤ìš° ìœ„í—˜í•œ ì§•í›„(Ominous sign). Cardiac Outputì´ ìˆœê°„ì ìœ¼ë¡œ 0ì´ ë˜ì—ˆë‹¤ëŠ” ëœ». ì‹¬í˜ˆê´€ ë¶•ê´´ ì§ì „.\n- **Fever:** ì•½ 15%ì—ì„œ ë¯¸ì—´ ë°œìƒ ê°€ëŠ¥. í ì¡°ì§ ê´´ì‚¬(Infarction)ë¡œ ì¸í•œ ì—¼ì¦ ë°˜ì‘. íë ´ìœ¼ë¡œ ì˜¤ì¸í•˜ì§€ ë§ ê²ƒ.\n---\n## 5. Pathophysiology: Mechanism of Death\ní™˜ìëŠ” ì™œ ì£½ëŠ”ê°€? (Hypoxia ë•Œë¬¸ì´ ì•„ë‹˜)\n1. **Obstruction:** í˜ˆì „ì´ íë™ë§¥ì„ ë§‰ìŒ.\n2. **RV Afterload Spike:** ìš°ì‹¬ì‹¤ì´ í”¼ë¥¼ ì§œë‚´ë ¤ëŠ”ë° ì••ë ¥ì´ ê¸‰ìƒìŠ¹.\n3. **RV Dilation & Septal Bowing:** ìš°ì‹¬ì‹¤ì´ ëŠ˜ì–´ë‚˜ë©´ì„œ ì‹¬ì‹¤ ì¤‘ê²©(Septum)ì„ **ì™¼ìª½(LV)ìœ¼ë¡œ ë°€ì–´ë²„ë¦¼**.\n4. **LV Compression:** ì¢Œì‹¬ì‹¤ì´ ì°Œë¶€ëŸ¬ì ¸ì„œ í”¼ë¥¼ ëª» ì±„ì›€ (Preload ê°ì†Œ).\n5. **Obstructive Shock:** ì¢Œì‹¬ì‹¤ì—ì„œ ë‚˜ê°€ëŠ” í”¼ê°€ ì—†ì–´ì„œ í˜ˆì•• ì¶”ë½ -> ì‚¬ë§.\n---\n## 6. Treatment Hierarchy (ê³„ì¸µë³„ ì¹˜ë£Œ)\ní™˜ìë¥¼ ì„¸ ê°€ì§€ ë²„í‚·(Bucket)ìœ¼ë¡œ ë¶„ë¥˜í•˜ì—¬ ì¹˜ë£Œí•¨.","subject":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","page_title":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","episode":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","section_path":["LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43"],"source_doc_id":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","source_page":null,"source_anchor":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43-21","focus_area":"LM_ pulmo 2 2f346f2986ee80569fd8ead7ca9bcf43","tags":["usmle-step2","core","treatment","pathophysiology"]}
